{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:47:18Z","timestamp":1792522038114,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to investigate the difference in resistance mechanisms and fitness of <jats:italic>Salmonella<\/jats:italic> Typhimurium (ST) and <jats:italic>Salmonella<\/jats:italic> Enteritidis (SE) mutants selected during the evolution of resistance under exposure to increasing ciprofloxacin concentrations <jats:italic>in vitro<\/jats:italic>. Mutations in quinolone target genes were screened by PCR. Phenotypic characterization included susceptibility testing by the broth dilution method, investigation of efflux activity and growth rate, and determination of the invasion of human intestinal epithelium cells <jats:italic>in vitro<\/jats:italic>. The two <jats:italic>Salmonella<\/jats:italic> serotypes exhibited differences in target gene mutations and efflux pump gene expression during the development of resistance. In the parental strains, ST had a competitive advantage over SE. During the development of resistance, initially, the SE strain was more competitive. However, once ciprofloxacin resistance was acquired, ST once again became the more competitive strain. In the absence of bile salts or at 0.1% bile, the growth rate of SE was initially greater than that of ST, but once ciprofloxacin resistance was acquired, ST had higher growth rates. ST strains showed decreased invasion of epithelial cells in 0.1% bile. These data indicate that ciprofloxacin-resistant ST strains are more competitive than ciprofloxacin-resistant SE strains.<\/jats:p>","DOI":"10.1038\/s41598-017-09151-y","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T14:28:09Z","timestamp":1502893689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro"],"prefix":"10.1038","volume":"7","author":[{"given":"Chuan-Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Xia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Zhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"9151_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/CMR.00066-12","volume":"26","author":"A F\u00e0brega","year":"2013","unstructured":"F\u00e0brega, A. & Vila, J. Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. Clinical microbiology reviews \n                           26, 308\u2013341 (2013).","journal-title":"Clinical microbiology reviews"},{"key":"9151_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1089\/fpd.2010.0787","volume":"8","author":"RS Hendriksen","year":"2011","unstructured":"Hendriksen, R. S. et al. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: results of quality assured laboratories from 2001 to 2007. Foodborne pathogens and disease \n                           8, 887\u2013900 (2011).","journal-title":"Foodborne pathogens and disease"},{"key":"9151_CR3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jac\/dki369","volume":"56","author":"S-H Choi","year":"2005","unstructured":"Choi, S.-H. et al. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. Journal of Antimicrobial Chemotherapy \n                           56, 1111\u20131114 (2005).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"9151_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1128\/AAC.47.2.827-829.2003","volume":"47","author":"FM Aarestrup","year":"2003","unstructured":"Aarestrup, F. M., Wiuff, C., M\u00f8lbak, K. & Threlfall, E. J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrobial Agents and Chemotherapy \n                           47, 827\u2013829 (2003).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"9151_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4315\/0362-028X-72.5.966","volume":"72","author":"J Miranda","year":"2009","unstructured":"Miranda, J., Mondragon, A., Martinez, B., Guarddon, M. & Rodriguez, J. Prevalence and antimicrobial resistance patterns of Salmonella from different raw foods in Mexico. Journal of Food Protection\u00ae \n                           72, 966\u2013971 (2009).","journal-title":"Journal of Food Protection\u00ae"},{"key":"9151_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","volume":"22","author":"J Strahilevitz","year":"2009","unstructured":"Strahilevitz, J., Jacoby, G. A., Hooper, D. C. & Robicsek, A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clinical microbiology reviews \n                           22, 664\u2013689 (2009).","journal-title":"Clinical microbiology reviews"},{"key":"9151_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica, K. et al. Quinolones: action and resistance updated. Current topics in medicinal chemistry \n                           9, 981\u2013998 (2009).","journal-title":"Current topics in medicinal chemistry"},{"key":"9151_CR8","doi-asserted-by":"publisher","first-page":"27668","DOI":"10.1074\/jbc.273.42.27668","volume":"273","author":"AB Khodursky","year":"1998","unstructured":"Khodursky, A. B. & Cozzarelli, N. R. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials. Journal of Biological Chemistry \n                           273, 27668\u201327677 (1998).","journal-title":"Journal of Biological Chemistry"},{"key":"9151_CR9","doi-asserted-by":"publisher","first-page":"224S","DOI":"10.1592\/phco.21.16.224S.33997","volume":"21","author":"DT Bearden","year":"2001","unstructured":"Bearden, D. T. & Danziger, L. H. Mechanism of action of and resistance to quinolones. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy \n                           21, 224S\u2013232S (2001).","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"9151_CR10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"DI Andersson","year":"2010","unstructured":"Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Reviews Microbiology \n                           8, 260\u2013271 (2010).","journal-title":"Nature Reviews Microbiology"},{"key":"9151_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000541","volume":"5","author":"LL Marcusson","year":"2009","unstructured":"Marcusson, L. L., Frimodt-M\u00f8ller, N. & Hughes, D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog \n                           5, e1000541 (2009).","journal-title":"PLoS Pathog"},{"key":"9151_CR12","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1128\/AAC.49.6.2343-2351.2005","volume":"49","author":"PK Lindgren","year":"2005","unstructured":"Lindgren, P. K., Marcusson, L. L., Sandvang, D., Frimodt-M\u00f8ller, N. & Hughes, D. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrobial Agents and Chemotherapy \n                           49, 2343\u20132351 (2005).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"9151_CR13","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1128\/AAC.05402-11","volume":"56","author":"A Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez, A. et al. Expression of OXA-type and SFO-1 \u03b2-lactamases induces changes in peptidoglycan composition and affects bacterial fitness. Antimicrobial agents and chemotherapy \n                           56, 1877\u20131884 (2012).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.icb.7100007","volume":"85","author":"B Coburn","year":"2007","unstructured":"Coburn, B., Grassl, G. A. & Finlay, B. Salmonella, the host and disease: a brief review. Immunology and cell biology \n                           85, 112\u2013118 (2007).","journal-title":"Immunology and cell biology"},{"key":"9151_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1099\/mic.0.26769-0","volume":"150","author":"A Prouty","year":"2004","unstructured":"Prouty, A., Brodsky, I., Falkow, S. & Gunn, J. Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology \n                           150, 775\u2013783 (2004).","journal-title":"Microbiology"},{"key":"9151_CR16","doi-asserted-by":"publisher","first-page":"24245","DOI":"10.1074\/jbc.M804544200","volume":"283","author":"E Nikaido","year":"2008","unstructured":"Nikaido, E., Yamaguchi, A. & Nishino, K. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. Journal of Biological Chemistry \n                           283, 24245\u201324253 (2008).","journal-title":"Journal of Biological Chemistry"},{"key":"9151_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijantimicag.2014.05.014","volume":"44","author":"L Li","year":"2014","unstructured":"Li, L. et al. Co-spread of oqxAB and bla CTX-M-9G in non-Typhi Salmonella enterica isolates mediated by ST2-IncHI2 plasmids. International journal of antimicrobial agents \n                           44, 263\u2013268 (2014).","journal-title":"International journal of antimicrobial agents"},{"key":"9151_CR18","doi-asserted-by":"crossref","unstructured":"Zhang, W.-H. et al. CTX-M-27 Producing Salmonella enterica Serotypes Typhimurium and Indiana Are Prevalent among Food-Producing Animals in China. Frontiers in microbiology \n                           7 (2016).","DOI":"10.3389\/fmicb.2016.00436"},{"key":"9151_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/mdr.2012.0090","volume":"19","author":"Y Gu","year":"2013","unstructured":"Gu, Y. et al. Functional Characterization of Quinolone-Resistant Mechanisms in a Lab-Selected Salmonella enterica Typhimurium Mutant. Microbial Drug Resistance \n                           19, 15\u201320 (2013).","journal-title":"Microbial Drug Resistance"},{"key":"9151_CR20","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1128\/AAC.48.10.4012-4015.2004","volume":"48","author":"DJ Eaves","year":"2004","unstructured":"Eaves, D. J. et al. Prevalence of mutations within the quinolone resistance-determining region of GyrA, GyrB, ParC, and ParE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrobial Agents and Chemotherapy \n                           48, 4012\u20134015 (2004).","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"9151_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1128\/AAC.00801-09","volume":"54","author":"E O\u2019Regan","year":"2010","unstructured":"O\u2019Regan, E. et al. Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrobial agents and chemotherapy \n                           54, 367\u2013374 (2010).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR22","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1128\/IAI.68.12.6763-6769.2000","volume":"68","author":"A Prouty","year":"2000","unstructured":"Prouty, A. & Gunn, J. Salmonella enterica serovar typhimurium invasion is repressed in the presence of bile. Infection and immunity \n                           68, 6763\u20136769 (2000).","journal-title":"Infection and immunity"},{"key":"9151_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jac\/dkg222","volume":"51","author":"J Ruiz","year":"2003","unstructured":"Ruiz, J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA GyrAse protection. Journal of Antimicrobial Chemotherapy \n                           51, 1109\u20131117 (2003).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"9151_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1128\/AAC.00600-06","volume":"51","author":"S Chen","year":"2007","unstructured":"Chen, S. et al. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar Typhimurium to fluoroquinolones and other antimicrobials. Antimicrobial agents and chemotherapy \n                           51, 535\u2013542 (2007).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, W.-H. et al. In Vitro Development of Ciprofloxacin Resistance of Salmonella enterica Serovars Typhimurium, Enteritidis, and Indiana Isolates from Food Animals. Microbial Drug Resistance (2017).","DOI":"10.1089\/mdr.2016.0119"},{"key":"9151_CR26","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1128\/AAC.48.10.3729-3735.2004","volume":"48","author":"S Baucheron","year":"2004","unstructured":"Baucheron, S. et al. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrobial agents and chemotherapy \n                           48, 3729\u20133735 (2004).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR27","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1128\/AAC.33.8.1318","volume":"33","author":"SP Cohen","year":"1989","unstructured":"Cohen, S. P., McMurry, L., Hooper, D., Wolfson, J. & Levy, S. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial agents and chemotherapy \n                           33, 1318\u20131325 (1989).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01229","volume":"2","author":"S Baker","year":"2013","unstructured":"Baker, S. et al. Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. Elife \n                           2, e01229 (2013).","journal-title":"Elife"},{"key":"9151_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jac\/dkf185","volume":"50","author":"P Sanchez","year":"2002","unstructured":"Sanchez, P. Fitness of in vitro selected Pseudomonas aeruginosanalB and nfxB multidrug resistant mutants. Journal of Antimicrobial Chemotherapy \n                           50, 657\u2013664, doi:10.1093\/jac\/dkf185 (2002).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"9151_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008029","volume":"4","author":"A Fabrega","year":"2009","unstructured":"Fabrega, A., Du Merle, L., Le Bouguenec, C., de Anta, M. T. J. & Vila, J. Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant. PLoS One \n                           4, e8029 (2009).","journal-title":"PLoS One"},{"key":"9151_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1128\/AAC.01005-08","volume":"53","author":"E O\u2019Regan","year":"2009","unstructured":"O\u2019Regan, E. et al. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrobial agents and chemotherapy \n                           53, 1080\u20131087 (2009).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9151_CR32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1099\/jmm.0.014092-0","volume":"58","author":"ME Merritt","year":"2009","unstructured":"Merritt, M. E. & Donaldson, J. R. Effect of bile salts on the DNA and membrane integrity of enteric bacteria. Journal of medical microbiology \n                           58, 1533\u20131541 (2009).","journal-title":"Journal of medical microbiology"},{"key":"9151_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/dkr414","volume":"67","author":"T Akiyama","year":"2012","unstructured":"Akiyama, T. & Khan, A. A. Molecular characterization of strains of fluoroquinolone-resistant Salmonella enterica serovar Schwarzengrund carrying multidrug resistance isolated from imported foods. Journal of antimicrobial chemotherapy \n                           67, 101\u2013110 (2012).","journal-title":"Journal of antimicrobial chemotherapy"},{"key":"9151_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijantimicag.2013.08.017","volume":"43","author":"C Ballest\u00e9-Delpierre","year":"2014","unstructured":"Ballest\u00e9-Delpierre, C. et al. Molecular study of quinolone resistance mechanisms and clonal relationship of Salmonella enterica clinical isolates. International journal of antimicrobial agents \n                           43, 121\u2013125 (2014).","journal-title":"International journal of antimicrobial agents"},{"key":"9151_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/jac\/dku423","volume":"70","author":"H Lofton","year":"2015","unstructured":"Lofton, H., Anwar, N., Rhen, M. & Andersson, D. I. Fitness of Salmonella mutants resistant to antimicrobial peptides. Journal of Antimicrobial Chemotherapy \n                           70, 432\u2013440 (2015).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"9151_CR36","doi-asserted-by":"publisher","first-page":"e01916","DOI":"10.1128\/mBio.01916-16","volume":"7","author":"MM Buckner","year":"2016","unstructured":"Buckner, M. M. et al. Beyond Antimicrobial Resistance: Evidence for a Distinct Role of the AcrD Efflux Pump in Salmonella Biology. mBio \n                           7, e01916\u201301916 (2016).","journal-title":"mBio"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09151-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:07:34Z","timestamp":1671786454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09151-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"assertion":[{"value":"16 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9113"}}